Related Experiment Video
Updated: May 29, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Update on liposarcoma: a review for cytopathologists.
1Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710-3712, USA. leslie.dodd@duke.edu
Diagnostic Cytopathology
|September 21, 2011
Summary
Liposarcoma (LS) is the most common soft tissue sarcoma, with four subtypes. Molecular signatures are crucial for accurate liposarcoma classification and distinguishing it from benign mimics.
Area of Science:
- Oncology
- Molecular Pathology
- Genetics
Background:
- Liposarcoma (LS) is the most frequent soft tissue sarcoma.
- LS comprises four distinct subtypes: well-differentiated, myxoid/round cell, pleomorphic, and mixed.
- Each subtype exhibits unique morphology, prognosis, and treatment strategies.
Purpose of the Study:
- To validate the current classification system of liposarcoma using molecular and cytogenetic findings.
- To highlight the molecular signatures of different liposarcoma subtypes.
- To demonstrate the utility of molecular data in distinguishing liposarcoma from benign mimics.
Main Methods:
- Analysis of molecular and cytogenetic findings in liposarcoma subtypes.
- Characterization of molecular alterations specific to each liposarcoma subtype.
- Comparison of molecular profiles to identify diagnostic markers.
Main Results:
- Well-differentiated LS shows MDM2 overexpression, inhibiting p53 tumor suppressor function.
- Myxoid/round cell LS is associated with a specific translocation impacting adipocyte differentiation.
- Pleomorphic LS exhibits multiple chromosomal abnormalities, typical of high-grade sarcomas.
Conclusions:
- Molecular signatures provide a validated basis for liposarcoma subtyping.
- Distinct molecular profiles aid in differentiating liposarcoma subtypes.
- Molecular analysis is essential for distinguishing liposarcoma from benign mimics.
